Why Adlai Nortye Ltd.’s (ANL) Stock Is Up 9.88%
As of Thursday, July 16, Adlai Nortye Ltd.’s ANL share price has surged by 9.88%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Adlai Nortye Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist which is in phase Ib and radiotherapy/chemoradiotherapy combination for the treatment of rectum cancer and esophageal cancer; and phase II trial for patients with moderate to high-risk rectal cancer. The company also develops AN9025, an oral small molecule pan-RAS(ON) inhibitor, which is in phase 1a clinical trials for the treatment of RAS-mutant cancers, including pancreatic, lung, and colorectal adenocarcinomas; AN4035, a proprietary CEACAM5-targeting antibody drug conjugate designed to deliver potent anti-tumor activity with an improved therapeutic window; and AN8025, a tri-specific antibody fusion protein which is in phase Ia clinical trial to treat advanced tumors. In addition, it develops AN4005, a small-molecule PD-L1 inhibitor that demonstrates antitumor activity by the blockade of PD-1/PD-L1 interaction which is in phase 1b clinical trial to activate cancer immunity. Further, the company is involved in technology transfer and consulting services business. Adlai Nortye Ltd. was founded in 2004 and is headquartered in North Brunswick, New Jersey.
Commentary & Analysis
Why Adlai Nortye Ltd.’s (ANL) Stock Is Up 5.65%
As of Wednesday, July 15, Adlai Nortye Ltd.’s ANL share price has surged by 5.65%, which has investors questioning if this is right time to sell.Michael Rose
Why Adlai Nortye Ltd.’s (ANL) Stock Is Down 8.24%
As of Friday, July 10, Adlai Nortye Ltd.’s ANL share price has dipped by 8.24%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Adlai Nortye Ltd.’s (ANL) Stock Is Down 8.26%
As of Wednesday, July 08, Adlai Nortye Ltd.’s ANL share price has dipped by 8.26%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Adlai Nortye Ltd.’s (ANL) Stock Is Up 6.85%
As of Monday, July 06, Adlai Nortye Ltd.’s ANL share price has surged by 6.85%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | ANL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $520.0 | $252.6 | 38% |
|
| Shares Out (Mil) | 32.0 | 52.3 | 38% |
|
| Institutional Ownership | 95.9% | 92.1% | 68% |
|
| Float (Mil) | 18.8 | 40.2 | 28% |
|
| Beta | 0.99 | 0.95 | 59% |
|
| Avg Daily Volume (000s) | 186 | 455 | 44% |
|
| Price Change (52-week) |
822.0% | 52.9% | 100% |
|
| Growth | ANL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | 11.3% | (9.9%) | 57% |
|
| EPS (5yr) | 32.0% | 16.0% | 82 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (22.6%) | (15.6%) | 29% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ANL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5 | $38 | 6% |
|
| Net Income (TTM) (Mil) | ($36) | ($43) | 19% |
|
| EPS (TTM) | ($1.111) | ($1.600) | 20% |
|
| Operating Cash Flow (TTM) (Mil) | ($34) | ($31) | 11% |
|
| Net Cash Flow (TTM) (Mil) | ($73) | $5 | 16% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $5 | 18% |
|
| Enterprise Value (Q1) (Mil) | $436 | $180 | 33% |
|
| Valuation | ANL | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.56 | na |
|
| P/E | na | 19.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | ANL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 63.8% | 96% |
|
| Net Margin | (710.6%) | (67.3%) | 1% |
|
| ROA | (43.2%) | (49.8%) | 13% |
|
| ROE | (106.5%) | (55.5%) | 9% |
|
| Liabilities to Assets | 124.2% | 30.3% | 97% |
|
| F-Score | 2 | 3 | 7% |
|
Adlai Nortye Ltd. did not pass any screens on 7/31/2026.
